Day Trading Calls in india

Day Trading Calls is a best type of technical and fundamental based services provided by capitalstars company .This types of services gives us a lot of profit in stock market.

stock Market

The stock market is one of the most important sources for companies to raise money.

join stock cash services with us

You can avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with us.

CAPITALSTARS RESEARCH FORUM

We have always worked to provide a challenging and professional work environment helped them to provide the best stock tips to our trading fraternity which produces profit every day. our main motto is client satisfaction which is comfortable with our services.

Nifty Futures Tips

You can avail Free Nifty/Bank Nifty futures Tips for two days to test our accuracy and if satisfied you can join this service with Capital Stars.

flying bird

Tricks and Tips
Showing posts with label cash sement. Show all posts
Showing posts with label cash sement. Show all posts

Wednesday, 22 May 2019

CLOSING BELL BY CAPITALSTARS : 22 MAY 2019

 capitalstars
        CS CLOSING BELL:
           NIFTY SPOT UP 
               28 @ 11737
        SENSEX SPOT UP  
             140 @ 39110
 BANK NIFTY FUTURES UP                     297 @ 30685
       HAPPY TRADING!!!!
WWW.CAPITALSTARS.COM                      7440449744


DAILY NIFTY SMART MOVERS 


SCRIPTS PRICE PRE. CLOSE CHANGE (%) CHANGE (Rs.) VOLUME   (IN 000S)                                                                                                                                               
Indusind Bank

1517.55   1447.55                    4.84    70.00             870.11

Bharat Electronics

100.90    96.80                      4.24      4.10             928.08

Tata Motors - DVR

85.65   83.10                     3.07      2.55              274.02

BHEL

65.25   63.35                     3.00      1.90             1224.67

Sun Pharma Inds.

420.65  408.70     2.92     11.95              443.65


DAILY NIFTY TOP LAGGARDS

SCRIPTS PRICE PRE. CLOSE CHANGE (%) CHANGE (Rs.) VOLUME (IN 000s)                                                                                                                                                           
Bosch

1687.55  17394.40              -3.37          -586.85          1.99

Tech Mahindra

750.00 773.45                     -3.03           -23.45          234.38

Indiabulls Housing

785.95 808.25                     -2.76           -22.30          1288.86

Yes Bank

137.70 141.00                    -2.34             -3.30           5214.23

Bharti Infratel

270.00 276.00                    -2.17            -6.00               54.78


BEST CALL OF THE DAY (FINAL TG )

FUTURE INTRADAY 

BUY LT FUT FINAL TGT 

OPTION INTRADAY 

BUY LT CALL 1460 FINAL TGT 

HNI FUTURE

SELL PIDILITIND FUT FINAL TGT 


Get more details here:
  Intraday stock tipsFinancial Advisory Company ,Derivative Free Trial,Stock tipsCall on:9977499927* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  


Opening Bell By Capitalstars : 22 May 2019

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 22 MAY 2019

 capitalstars
CS OPENING BELL:
NIFTY SPOT UP 34@11743
SENSEX SPOT UP 151@39121
BANK NIFTY FUTURES UP 41@30430
HAPPY TRADING!

CS NIFTY FUTURES (MAY) OVERVIEW 

TREND BULLISH
RES 2: 12000
RES 1: 11890
SUP 1: 11520
SUP 2: 11400

CS BANK NIFTY FUTURES (MAY) OVERVIEW
TREND BULLISH 
RES 2: 31000
RES 1: 30750
SUP 1: 30180
SUP 2: 30000

Get more details here:
Call on:9977499927
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  

Tuesday, 21 May 2019

CORPORATE NEWS BY CAPITALSTARS 21 MAY 2019

 capitalstars
Glenmark Pharma gets USFDA nod for Solifenacin Succinate tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Solifenacin Succinate Tablets, 5 mg and 10 mg, a generic version of Vesicare Tablets, 5 mg and 10 mg1, of Astellas Pharma US, Inc.
According to CQ VIA sales data for the 12-month period ending March 2019, the Vesicare Tablets, 5 mg and 10 mg market achieved annual sales of approximately $942.7 million.
Glenmark's current portfolio consists of 154 products authorized for distribution in the U.S. marketplace and 58 and spending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

GAIL India to consider bonus issue on May 27
GAIL India, in its press note to the exchanges, informed that the company's board will meet on May 27 to consider bonus issue.
"The board of directors will also consider, the audited financial results for the quarter/ year ended on March 31, 2019, and also to consider the recommendation of final dividend for FY19, if any," the company said in a press note after markets hours to the exchanges on Monday.

Thyrocare Techs founder offers to buy entire companies stake in a unit
Thyrocare Tech, in its press note to the exchanges, informed that Dr A. Velumani, Chainnan, Managing Director & CEO has offered to buy the entire shareholding of the company in Nuclear Healthcare Limited (NHL), the wholly owned subsidiary.
The offer made at the current investment value of Rs194.67cr to ensure that there is no loss to the public shareholders, the company said in a press note to the exchanges on Tuesday.

BHEL commissions two more units of Kaleshwaram project
Bharat Heavy Electricals Limited (BHEL) has successfully commissioned two more pumping units (Units 3&4) of 116 MW each, of the 7x116 MW Kaleshwaram Lift Irrigation Scheme (LIS) Package-6 in Telangana.
BHEL had earlier commissioned units 1&2 of the same project in April 2019. Significantly, the pump for each unit is designed to lift 89.16 cumecs (cubic metres per second) of water by 105.5 metres.

Alembic Pharma receives USFDA approval for Solifenacin Succinate
Alembic Pharma, in its filing to the exchanges on Tuesday, informed that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Solifenacin Succinate Tablets, 5 mg, and 10 mg, reacting to this, shares of the company climbed 1% on the BSE.
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Vesicare Tablets, 5 mg, and 10 mg, of Astellas Pharma US, Inc. Solifenacin Succinate Tablet is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Get more details here:
Call on:9977499927
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  

Monday, 20 May 2019

CORPORATE NEWS BY CAPITALSTARS : 20 MAY 2019

 capitalstars
Dr. Reddy's declines 7% post Q4FY19 numbers
Shares of Dr. Reddy's declined 7% on Monday in an otherwise strong market despite the company reporting a healthy set of numbers for the quarter, it was in-line on revenue and EBITDA fronts, but ahead on the PAT front.
The company reported revenue growth of 13.4% YoY to Rs4, 029.6cr, broadly in-line with consensus estimates. Due to lower selling and other expenses, EBITDA reported 45.3% YoY growth to Rs818.9cr, in-line with estimates. EBITDA margins stood at 20.3%, 446bps expansion on YoY basis. Led by strong EBITDA growth, company reported PAT of Rs455.4cr, 67.4% YoY growth and ~9% ahead of consensus estimates.

Bharat Forge's Q4FY19 PAT at Rs300cr
Bharat Forge reported Q4FY19 net profit at Rs300cr against Rs100cr in the same quarter last fiscal.
Revenue of the company for Q4FY19 increased by 14% YoY at Rs1,668cr vs. Rs1,467cr in the same period a year ago. Further, EBITDA rose to Rs516cr vs. Rs418cr a year ago.
"FY19 has been a record year for the company with strong revenue and profit growth. In FY19, the company registered a revenue growth of 22.6% and PAT growth of 51.5%. For the quarter, revenues grew by 13.8%, while PAT grew by 198.3% on a YoY basis. We continued to strengthen the balance sheet with all key financial ratios improving compared to FY2018 'SB.N. Kalyani, Chairman & Managing Director of Bharat Forge said.

PSU Bank stocks outperform; Indian Bank, Bank of India stocks surge
The Nifty PSU Bank index was trading 7% up in the morning session on Monday on heavy buying in Indian Bank, Bank of India and Canara Bank.
SBI and Syndicate Bank leads the index's gain by witnessing rally of 8% each. Allahabad Bank and Bank of Baroda also gained 8-9% respectively. PNB, Oriental Bank, Union Bank, J&K Bank, and Central Bank also joined the gainers' group by rising 4-6% respectively.

Jet Airways director Robin Kamark resigns from board
Jet Airways (India) announced that Robin Kamark, nominee director of Etihad Airways PJSC, resigned as director of the Company with effect from May 16, 2019.
The company announced this after-market hour on Friday.
Also, Kuldeep Sharma, Company Secretary and Compliance Officer of the Company, vide his letter dated May 14, 2019, has resigned from the services of the Company with immediate effect, the company said in the filing.

USFDA inspection at Cipla's Indore plant ends with zero observations
Cipla, in its filing to the exchanges, informed that inspection conducted by the United States Food and Drug Administration (USFDA) at the company's Indore facility ended with zero observation.
"USFDA conducted a post-approval inspection at the company's Indore facility from May 13 to May 17, 2019", the company said in a press note after markets hours to the exchanges on Friday.

Get more details here:
Call on:9977499927
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  

Sunday, 19 May 2019

Market Live: Nifty likely to open higher.

capitalstars
The Nifty50 is likely to open with a gap of over 100-150 points in morning trade on Monday tracking Exit Poll results and positive trend seen in other Asian markets. Wall Street ended lower on Friday as continuing trade tensions pulled industrial and tech shares down, and the Dow capped a fourth straight week of losses in its longest weekly losing streak in three years. Trends on SGX Nifty indicate a gap up opening for the broader index in India, a jump of 242 points or 2.12 percent. Nifty futures were trading around 11,677-level on the Singaporean Exchange. On the earnings front, as many as 86, companies will declare their results for the quarter ended March later today which include names like Astral Poly, Bharat Forge, BPCL, HEG, Jindal Stainless, Kitex Garments, Tata Motors, Torrent Pharma, United Breweries, etc. among others.

Global Market:

Asian Markets: Asian markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.73% while the Hang Seng is down 0.50%. The Nikkei 225 is not trading.US Markets: North and South American markets finished mixed to lower as of the most recent closing prices. Shares in U.S. fell as the S&P 500 dropped 0.58%. The Bovespa lost 0.04% while the IPC in Mexico closed unchanged.European Markets: European markets finished lower on Friday with shares in Germany leading the region. The DAX is down 0.58% while France's CAC 40 is off 0.18% and London's FTSE 100 is lower by 0.07%.

Major Headlines of the day:

Rupee opens at 69.49 per dollar.

Reliance Capital protests CARE Ratingsâ downgrade action The company expects to realize minimum proceeds of over Rs10,000cr and sharply cut its overall debt by more than 50% within the current financial year.
Fortis Healthcare's arm to sell 28.89% stake in MSCL The proposed transaction is subject to the approval of FHIL shareholders as well as regulatory approval if required.
USFDA inspection at Cipla's Indore plant ends with zero observations USFDA conducted a post-approval inspection at the company's Indore facility from May 13 to May 17, 2019.

Earnings Reaction To Watch

BHARATFORGBPCLHPCLTATAMOTORSTORRENT PHARMA

The trend in FII flows:- The FIIs were Net Value of Rs -1057.82 segments while the DIIs were Net Value of 1809.76 the provisional figures.
Securities in Ban For Trade Date 20-MAY-2019JETAIRWAYS



Investment  trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
 
For more details call on 9977499927 or visit our website www.capitalstars.com

Friday, 4 January 2019

MARKET WRAP UP 04-JAN-2019


Closing Bell: Sensex ends the week with a gain of 181 pts, Nifty above 10,700.

Buying counters were buzzing in the last couple of hours for the market, helping them not only recover from low points, but also end the week on a strong note.
Except IT names, investors bought across sectors, with maximum gains seen among metals, energy and banks, among others. The Nifty Midcap index ended higher too. 
At the close of market hours, the Sensex was up 181.39 points or 0.51% at 35695.10, and the Nifty up 55.10 points or 0.52% at 10727.40. The market breadth was narrow as 1322 shares have advanced, against a decline of 1255 shares, and 159 shares are unchanged.
Yes Bank, Vedanta, and Bharti Infratel gained the most, while Infosys, TCS, HCL Tech and Tech Mahindra were the top losers.



HEADLINES OF THE DAY

Aviation industry continues to face turbulence, fall in oil prices likely to offer respite
NHPC said Dulhasti Power Station (390 MW) in Jammu & Kashmir has been under complete shutdown w.e.f. 03.01.2019 to 12.01.2019 (tentative) for the work of 'replacement of By-Pass Line valves of MIV'.
Manappuram Finance has made interest payment due on January 1, 2019.
Chinese Central Bank cut bank's reserve requirement ratio by 100 bps.
European shares traded higher following news that the US and China will hold trade talks next week.


The crucial resistance for Nifty spot is now seen at 10860 and above this 10980 Support for the immediate term is now placed at 10620 next support will be 10480.


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Wednesday, 2 January 2019

MARKET WRAP UP 2-jan-2018



Closing Bell: Sensex ends over 350 points lower, Nifty gives up 10,800; autos, metal drag.

Equities have ended the session off low points, but still in the red. Weak global and domestic cues weighed on the indices. The Nifty managed to give up 10,800.
Weakness was visible among automobiles, banks, energy, metals and pharmaceuticals. The Nifty Midcap index, too, fell over a percent during the trade. 
At the close of market hours, the Sensex was down 363.05 points or 1.00% at 35891.52, while the Nifty down 117.60 points or 1.08% at 10792.50. The market breadth is negative as 941 shares advanced, against a decline of 1,577 shares declined, while 169 shares were unchanged. Sun Pharma and TCS were the top gainers, while Vedanta, M&M, Eicher Motors and JSW Steel lost the most. 


HEADLINES OF THE DAY
Essel Propack is issuing Commercial Papers (CP) for Rs 35 crore on private placement basis.
SVL has delayed payment of interest for listed NCDs on the due date 
Jet Airways plunges over 5% after default on payment, rating downgrade
Bajaj Electricals approves ffundraising Board approved a proposal to raise Rs 250 crore by way of issue of debt securities in the form of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) on a Private Placement basis. ICRA downgraded long-terminating of Jet Airways to D from C. The short-term rating has been revised to D from A4.



Infosys to announce Q3 earnings on January 11
Capacite Infraprojects rose 4 percent after cthe ompany received contract worth Rs 97.69 crore.
Vedanta slips 3.7 percent: The company shares are trading lower after the Tamil Nadu government moved Supreme Court against the order of National Green Tribunal allowing reopening of Sterlite's Tuticorin unit.
TCS to announce Dec quarter results on January 10
NCC wins order: NCC has received four new orders totaling to Rs 2,890.7 crore in the month of December, 2018.
Hero MotoCorp pitches for 18% GST on two-wheelers

The crucial resistance for Nifty spot is now seen at 10860 and above this 11110 Support for the immediate term is now placed at 10620 next support will be 10480.




Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647